CRIS Current Research Information System

PASCALE, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.849
NA - Nord America 3.302
EU - Europa 2.665
SA - Sud America 315
AF - Africa 231
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.199
SG - Singapore 1.347
CN - Cina 1.295
VN - Vietnam 1.119
IT - Italia 1.039
HK - Hong Kong 310
DE - Germania 307
SE - Svezia 282
KR - Corea 236
BR - Brasile 205
GB - Regno Unito 200
IN - India 172
FR - Francia 164
NL - Olanda 129
IE - Irlanda 111
JP - Giappone 97
RU - Federazione Russa 94
CI - Costa d'Avorio 84
FI - Finlandia 82
CA - Canada 62
BG - Bulgaria 44
AR - Argentina 41
AT - Austria 39
JO - Giordania 36
TG - Togo 36
IQ - Iraq 33
ID - Indonesia 32
ZA - Sudafrica 31
TH - Thailandia 26
CH - Svizzera 25
BD - Bangladesh 24
ES - Italia 24
TR - Turchia 23
AU - Australia 22
MX - Messico 22
PH - Filippine 22
BE - Belgio 21
NG - Nigeria 21
PK - Pakistan 20
UA - Ucraina 19
PL - Polonia 17
CO - Colombia 16
CL - Cile 15
EC - Ecuador 14
SC - Seychelles 14
RO - Romania 12
SA - Arabia Saudita 12
EG - Egitto 8
PE - Perù 8
TW - Taiwan 8
DZ - Algeria 7
LT - Lituania 7
GR - Grecia 6
PY - Paraguay 6
TN - Tunisia 6
AL - Albania 5
EE - Estonia 5
IR - Iran 5
MA - Marocco 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
HN - Honduras 4
HR - Croazia 4
MY - Malesia 4
PA - Panama 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
JM - Giamaica 3
KE - Kenya 3
LY - Libia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MK - Macedonia 2
NE - Niger 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
Totale 11.370
Salva come PNG Salva come JPEG
Città #
Singapore 942
Hefei 495
Ashburn 475
Chandler 317
Ho Chi Minh City 300
Hong Kong 287
Hanoi 270
San Jose 242
Seoul 211
Bologna 209
Santa Clara 165
Southend 125
Dallas 122
Beijing 111
Dublin 111
Fairfield 107
Milan 95
Abidjan 84
Los Angeles 83
Princeton 80
Tokyo 80
Boardman 76
Lauterbourg 73
New York 71
Ann Arbor 68
Council Bluffs 63
Da Nang 52
Bengaluru 51
Helsinki 51
Wilmington 51
Rome 47
Woodbridge 46
Bremen 44
Florence 44
Houston 44
Seattle 43
Sofia 43
Munich 40
Haiphong 38
Lomé 36
Amman 35
Redondo Beach 33
Turin 31
São Paulo 30
Vienna 30
Frankfurt am Main 29
Berlin 28
Shanghai 26
Buffalo 25
Jakarta 23
Cambridge 22
The Dalles 22
Bern 21
Chicago 21
Lappeenranta 21
Nuremberg 20
Orem 20
Amsterdam 19
Johannesburg 19
Brussels 18
London 18
Victoria 18
Abeokuta 17
Redmond 17
Des Moines 16
Modena 16
Toronto 16
Falkenstein 15
Paris 15
Redwood City 15
Guangzhou 14
Montreal 14
Quận Bình Thạnh 14
Tongling 14
Baghdad 13
Biên Hòa 13
Can Tho 13
Jinan 13
Castel Maggiore 12
Denver 12
Hải Dương 12
Washington 12
Westminster 12
Adelaide 11
Atlanta 11
Changsha 11
Ha Long 11
Naples 11
Phoenix 11
Stockholm 11
Thái Nguyên 11
Xi'an 11
Bangkok 10
Bogotá 10
Boydton 10
Bến Tre 10
Ferrara 10
Nanjing 10
Padova 10
Turku 10
Totale 6.895
Salva come PNG Salva come JPEG
Nome #
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 323
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 256
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 254
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 252
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 248
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 245
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 240
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 240
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 227
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 225
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 218
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 197
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 197
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 195
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 193
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 190
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 190
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 189
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 182
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 174
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 163
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 163
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 162
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 161
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 161
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 158
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 157
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 156
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature 155
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 154
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 153
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 152
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 151
CMV-RNAemia as new marker of active viral replication in transplant recipients 149
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 147
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized with COVID-19 Pneumonia: A Randomized Clinical Trial 147
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 144
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review 142
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections 141
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 141
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study 140
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 139
The Role of Microbes in Surgical Decision Making for Infective Endocarditis: Mitral Valve Repair or Replacement? 136
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 136
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 135
‘Treatment duration for Escherichia coli bloodstream infection and outcomes’ – Author's reply 135
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 134
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 131
Infections Management in the Lung Transplant Setting in Italy: A Web-Survey 125
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 124
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences 123
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicenter observational study (CarDINe Study) 123
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 123
Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots 119
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 118
Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature 115
Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies 107
Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature 104
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 103
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 101
Prognostic role of aetiological agent vs. clinical pattern in candidates to lead extraction for cardiac implantable electronic device infections 101
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in solid organ transplant recipients 97
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 96
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 91
null 91
Epidemiology and antibiotic resistance in a large italian teaching hospital 89
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 84
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 83
Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study 79
null 78
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 75
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 74
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 72
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful? 67
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection 65
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study 58
Sphingomonas paucimobilis osteomyelitis in an immunocompetent patient. A rare case report and literature review 50
Intestinal helminths in immigrants in Naples (Italy): A comparison between two different diagnostic techniques 49
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections 46
Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort study 43
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study 41
SARS-CoV-2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS 37
Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot 32
From clinical trials to daily practice: How to adequately administer sulbactam-durlobactam? alone or combined with imipenem? 27
Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause-or-Consequence Dilemma 26
Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study 24
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block? 22
How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: The role of [18F]-FDGCT/CT imaging-An international multidisciplinary survey 21
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction? 13
Totale 11.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 24 87
2021/2022810 18 10 25 77 63 41 26 54 78 113 181 124
2022/20231.346 89 161 61 191 106 122 35 104 255 48 103 71
2023/2024656 72 69 33 60 46 100 31 36 35 61 50 63
2024/20252.342 87 199 210 218 274 129 168 92 64 201 232 468
2025/20265.848 625 811 581 582 545 274 704 171 1.091 452 12 0
Totale 11.694